Palmar-plantar erythrodysestasia syndrome associated with 5-fluorouracil treatment.

Anticancer Res

Divisione di Oncologia Medica, Ospedale Oncologico San Giovanni Antica Sede, Torino, Italy.

Published: January 1994

Palmar-Plantar Erythrodysestasia Syndrome (PPES) or Hand-Foot Syndrome (H&F S) is an underestimated adverse reaction to chemotherapeutic agents, mainly related to 5-Fluorouracil. From March 1991 to February 1992, at the San Giovanni Oncologic Hospital of Torino, we observed 12 out of 163 patients (7.3%) displaying PPES while being treated with 5-FU containing regimens. No correlation with type of neoplastic disease, sex, age and total dose of administered 5FU was observed. Dose reductions or drug suspension achieved PPES reversal. The etiopathogenesis remains unclear. Both an idiosyncratic pattern and cutaneous drug accumulation are suggested.

Download full-text PDF

Source

Publication Analysis

Top Keywords

palmar-plantar erythrodysestasia
8
erythrodysestasia syndrome
8
syndrome associated
4
associated 5-fluorouracil
4
5-fluorouracil treatment
4
treatment palmar-plantar
4
syndrome ppes
4
ppes hand-foot
4
hand-foot syndrome
4
syndrome h&f
4

Similar Publications

Palmar-plantar erythrodysestasia syndrome associated with 5-fluorouracil treatment.

Anticancer Res

January 1994

Divisione di Oncologia Medica, Ospedale Oncologico San Giovanni Antica Sede, Torino, Italy.

Palmar-Plantar Erythrodysestasia Syndrome (PPES) or Hand-Foot Syndrome (H&F S) is an underestimated adverse reaction to chemotherapeutic agents, mainly related to 5-Fluorouracil. From March 1991 to February 1992, at the San Giovanni Oncologic Hospital of Torino, we observed 12 out of 163 patients (7.3%) displaying PPES while being treated with 5-FU containing regimens.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!